| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 8 securities · passive | ||||||
|
ZimVie Inc.
13G/A
ZIMV · 98888T107
|
0% |
8/27/2025
Event 7/21/2025
|
||||
| Camber Capital Management LP | 0% | |||||
| Stephen DuBois | 0% | |||||
|
Brookdale Senior Living Inc.
13G/A
BKD · 112463104
|
2.7% |
5/16/2025
Event 3/31/2025
|
||||
| Camber Capital Management LP | 2.7% | |||||
| Stephen DuBois | 2.7% | |||||
|
OraSure Technologies, Inc.
13G/A
OSUR · 68554V108
|
1.2% |
5/15/2025
Event 3/31/2025
|
||||
| Camber Capital Management LP | 1.2% | |||||
| Stephen DuBois | 1.2% | |||||
|
Inogen Inc
13G/A
INGN · 45780L104
|
3.7% |
5/15/2025
Event 3/31/2025
|
||||
| Camber Capital Management LP | 3.7% | |||||
| Stephen DuBois | 3.7% | |||||
|
PTC Therapeutics, Inc.
13G/A
PTCT · 69366J200
|
4.2% |
2/14/2025
Event 12/31/2024
|
||||
| Camber Capital Management LP | 4.2% | |||||
| Stephen DuBois | 4.2% | |||||
|
Puma Biotechnology Inc
13G/A
PBYI · 74587V107
|
0% |
2/14/2025
Event 12/31/2024
|
||||
| Camber Capital Management LP | 0% | |||||
| Stephen DuBois | 0% | |||||
|
Myriad Genetics, Inc.
13G/A
MYGN · 62855J104
|
3.4% |
2/14/2025
Event 12/31/2024
|
||||
| Camber Capital Management LP | 3.4% | |||||
| Stephen DuBois | 3.4% | |||||
|
Solid Biosciences Inc.
13G/A
SLDB · 83422E105
|
0% |
2/14/2025
Event 12/31/2024
|
||||
| Camber Capital Management LP | 0% | |||||
| Stephen DuBois | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.